O bstructive sleep apnea (OSA) may affect 15e20% of obese pregnant women; one-half of all pregnant women in the United States are overweight or obese. [1] [2] [3] [4] [5] OSA is associated with several comorbidities in pregnancy: hypertensive disorders of pregnancy, gestational diabetes mellitus, and cardiomyopathy. 3, [6] [7] [8] [9] [10] [11] These associations are significant after investigators control for obesity, which is an important confounder that is associated with both OSA and adverse maternal outcomes. Large, retrospective database studies have also shown increased morbidity and mortality rates for pregnant women with OSA. 8, 11 Some recent studies also suggest adverse fetal and neonatal outcomes that are associated with maternal OSA, although the results of these studies have been inconsistent. 9, 12, 13 Women with OSA in pregnancy have a 2-fold increased risk of the development of preeclampsia and a 1.5e3.5-fold increased risk of the development of gestational diabetes mellitus after investigators control for obesity. 3, 8, 11 Despite the association of OSA with adverse pregnancy outcomes and interest in the identification of these women so that treatment can be initiated, screening for OSA in pregnancy has remained a challenge. The gold-standard method of the diagnosis of OSA is inlaboratory, overnight polysomnography, which is a diagnostic test that is time-consuming and costly to implement on a wide scale. Furthermore, wait times for in-laboratory polysomnography in many healthcare settings range from 2e3 months or longer; this poses an additional hurdle to the timely diagnosis and treatment of OSA during a woman's pregnancy. As an alternative to polysomnography, portable at-home, unattended sleep apnea testing is emerging as a reliable, convenient, and cost-effective method of screening for OSA in some populations and has been used in several studies of OSA in pregnancy. [2] [3] [4] 6, 14 However, these home sleep apnea tests are impractical to administer as a primary screening tool, and a number of investigators have tried to validate established OSA screening questionnaires in parturients or to create new screening tools that would help identify which pregnant women should be referred for further diagnostic sleep testing. 2, 12, [14] [15] [16] In pregnancy, these Original Research ajog.org screening tools are associated with a high false referral rate for polysomnography. 17 The proportion of obese women in these cohorts ranged from approximately 20e50%, but none enrolled only women with extreme obesity (body mass index [BMI] , !40 kg/m 2 ). 18 In each of these studies, BMI or prepregnancy BMI was an important risk factor for the prediction of OSA status in pregnancy; further, BMI has been established as an important risk factor for OSA in nonpregnant populations. 19 The purpose of this study was to evaluate established OSA screening questionnaires, a sleepiness scale, their individual component items, and physical examination findings in a cohort of pregnant women with extreme obesity in mid pregnancy with the use of objective home sleep testing to determine OSA status and to describe the prevalence of OSA among women with extreme obesity. The questionnaires have not been found to be useful in other studies of pregnant women, but they have not been tested previously in a cohort of extremely obese women.
Materials and Methods
This study was approved by the Duke University Medical System Institutional Review Board and registered in ClinicalTrials.gov (NCT02383706). We prospectively enrolled adult pregnant, nulliparous, and multiparous subjects who were 24e35 weeks gestation from a university-affiliated prenatal clinic. Women were included if they had a BMI !40 kg/m 2 at the time of enrollment and were !18 years old. The World Health Organization classification of obesity was used to define class 3 (extreme) obesity. 18 Women with an established diagnosis of OSA or chronic opiate use and subjects who did not speak English were excluded. After informed consent, demographic data were recorded (including prepregnancy BMI from chart review), and the subjects completed 3 sleep disordered breathing screening questionnaires: the Berlin Questionnaire 20 (BQ), the STOP-BANG 19, 21, 22, 25 questionnaire, and the American Society of Anesthesiologists' (ASA) checklist. 23 Subjects also completed the Epworth Sleepiness Scale (ESS), which is used to assess sleepiness that can be associated with OSA. 24 An OSA risk score was also calculated for each subject with the use of the method proposed for use in pregnant women by Facco Similarly, the ASA checklist contains 12 items in 3 categories: (1) clinical signs and symptoms, (2) history of apparent airway obstruction during sleep, and (3) somnolence. If !2 of these categories are endorsed, the patient is considered at high risk for OSA. 23 Each item on the STOP-BANG questionnaire receives 1 point, with the highest total possible score in this cohort equal to 6 (because male gender and age >50 years do not apply to any of the subjects). 19, 25 The ESS is considered concerning for excessive daytime sleepiness if scores are in the 11e24 range. 24 Study data were entered into and managed with the use REDCap electronic data capture tools hosted at Duke University. REDCap (Research Electronic Data Capture) is a secure, webbased application designed to support data capture for research studies, providing (1) an intuitive interface for validated data entry, (2) audit trails for tracking data manipulation and export AJOG at a Glance Why was this study conducted? This study was conducted to test established obstructive sleep apnea screening tools and their individual component items in a cohort of extremely obese pregnant women with the use of objective testing to determine obstructive sleep apnea status and to describe the prevalence of obstructive sleep apnea among mid-pregnancy pregnant women with body mass index !40 kg/m 2 (extreme obesity).
Key Findings
The key findings of this study are that nearly one-quarter of pregnant women with extreme or class 3 obesity have obstructive sleep apnea on home sleep apnea testing in mid pregnancy and that previously defined obstructive sleep apnea screening tools (Berlin Questionnaire, STOP-BANG questionnaire, American Society of Anesthesiologists checklist, and Epworth Sleepiness Scale) perform very poorly to screen for obstructive sleep apnea in this cohort. The obstructive sleep apnea in pregnancy prediction score by Facco et al was significantly associated with obstructive sleep apnea status, but its risk stratification had very low specificity with 84% of the subjects in our cohort who were identified as high risk. Age, body mass index, neck circumference, frequently witnessed apneas, and likely to fall asleep while driving were associated most strongly with obstructive sleep apnea status.
What does this add to what is known?
This study is the first to show that, in a cohort of pregnant women with extreme (class 3) obesity, clinical risk factors that include age, body mass index, and neck circumference are important risk factors for obstructive sleep apnea and may require pregnancy-specific thresholds and that none of the established obstructive sleep apnea screening tools provide adequate or informative assessments of obstructive sleep apnea status in this cohort. It also showed that endorsement of frequently witnessed apneas and falling asleep while driving were associated with obstructive sleep apnea status.
Original Research OBSTETRICS ajog.org procedures, (3) automated export procedures for seamless data downloads to common statistical packages, and (4) procedures for importing data from external sources. 26 Vital signs were recorded, and subjects underwent a physical examination of the neck and upper airway by trained research assistants in the Department of Anesthesiology to measure neck circumference 22 and thyromental distance and to assess retrognathia, tongue scalloping, 27 Mallampati score (MMS), 28 modified MMS, 29 tonsil size, and lateral pharyngeal wall narrowing. MMS is a 1e4 numeric rating system that commonly is used to assess the airway and predict difficulty of intubation that is assessed by asking the subject to open their mouth as wide as possible with the tongue protruding. The modified MMS leaves the tongue inside the mouth. Neck circumference was measured with a disposable measuring tape at the midpoint of the neck just below the thyroid cartilage. Thyromental distance was measured with a disposable paper measuring tape from the mandible to the top of the thyroid cartilage. Retrognathia, tongue scalloping, MMS, modified MMS, tonsil size, and lateral pharyngeal wall narrowing were rated with the use of an illustrated numeric scoring tool.
Subjects received an unattended type III home sleep apnea test (ApneaLink Air; ResMed, Poway, CA) and instructions for wearing it during 1 night of sleep. The home sleep test consists of a pulse oximeter for recording of oxygen saturation and heart rate, a respiratory effort belt for measurement of respiratory effort, and a nasal sensor for detection of flow limitation, Apnea-Hypopnea Index (AHI), and snoring. The software on the device calculates AHI from the sum average number of apneas (80e100% reduction in airflow with respiratory effort !10 seconds) and hypopneas (50e80% reduction in airflow with respiratory effort ! 10 seconds) per hour during the recording time, based on the standard definitions of the American Academy of Sleep Medicine. 30 The software also generates a report with details regarding variation in oxygen saturation during the study. Subjects with an AHI >5 per hour on the home sleep test were referred to a sleep medicine physician for further evaluation.
Pregnancy outcomes that included maternal death, gestational diabetes mellitus, cerebrovascular accident, spontaneous labor, induction of labor, oxytocin administration during labor, cesarean delivery, estimated blood loss, neonatal weight, composite outcomes of adverse maternal cardiovascular and peripartum events, and adverse fetal outcomes were followed for all subjects. A composite adverse maternal cardiovascular outcome combined cases of gestational hypertension, mild and severe preeclampsia, eclampsia, cardiomyopathy, and congestive heart failure. A composite adverse peripartum outcome included cases of postpartum hemorrhage, maternal intensive care unit admission, and postoperative wound infections. A composite adverse fetal outcome included cases of neonatal intensive care unit admission, fetal growth restriction, preterm delivery (<37 weeks gestation), and fetal death.
OSA outcome was defined as AHI !5 events per hour among patients with at least 2 hours of recorded nasal air flow time. This measure was chosen to assess outcome because it represents the threshold for referral for in-laboratory polysomnography, and an OSA screening measure must be able to indicate sensitively and specifically when a referral for polysomnography is needed. We summarized the patient demographic, physical and clinical characteristics and the questionnaire responses in each outcome group. We assessed univariate associations of patient characteristics and questionnaire responses with OSA outcome via t-test or Wilcoxon rank sum test for numeric variables, and chi-square test or Fisher Exact test for categoric variables.
We assessed the performance and agreement of the previously defined OSA risk scores with the use of receiver operating curve (ROC) area under the curve analysis, logistic regression, and Kendall Tau correlation for the numeric scores and with the use of sensitivity and specificity, net reclassification indices, and Kappa statistics for the binary risk stratification.
We designed the study with an expectation of an OSA-positive rate of 30e40% in our high-risk population.
1,2 A study of 80 patients (24e32 with OSA) with completed valid home sleep test achieves 79% power in a logistic regression with a 2-sided alpha score of .05 to detect an odds ratio of 2.5 for a numeric risk score when the OSA rate is 35%. For the Kappa statistic used to assess agreement with 80 subjects and an OSA rate of 35%, we will achieve 82% power at an alpha score of .05 to detect the difference between a kappa of 0.45 (fair agreement) and 0.75 (strong agreement). Power and sample size calculation were performed in NQuery software (NQuery version 7, Statistical Solutions Ltd, Boston, MA); statistical analysis was performed in SAS software (version 9.4; SAS Inc, Cary, NC). Significance was set at .05 level.
Results
To collect a detailed home sleep test of the required 80 subjects, we enrolled 108 subjects in the study from March 2015 until August 2017. Twelve subjects did not complete the home sleep study. Sixteen subjects were excluded because of improperly wearing the device or wearing the device for <2 hours. Eighty subjects completed valid, home sleep tests of !2 hours.
Nineteen women (24%) had AHI !5 events per hour on their home sleep test. Sixteen of these subjects had mild OSA, defined as AHI 5 to 14.9 per hour (mean AHI per hour AE standard deviation, 7.8 AE 2.5; range, 5e12.1). Two subjects had moderate OSA, defined as AHI 15e29.9 per hour (AHI ¼ 16 and 28 per hr). Only 1 subject had severe OSA, defined as AHI > 30 per hour (AHI ¼ 47 per hr). Women with OSA were significantly older and of higher BMI than women without OSA (Table 1 ). There was no significant difference in chronic hypertension diagnosis or gestational age at enrollment between the 2 groups. 68% and 26% of our cohort self-identified as African American or white, respectively; the remaining women self-identified as either multiple races/ethnicities or Hispanic. There was no significant association between race/ethnic group and Of all the individual component items and physical examination findings on the OSA screening assessments that were administered, only a few were associated significantly with AHI !5 per hour (Supplementary Table) . Neck circumference was greater in pregnant subjects with OSA compared with those with AHI <5 per hour (mean, 42.1AE3.0 cm vs 40.6AE2.7 cm; P¼.05). Subjects who responded affirmatively to the question "Has anyone noticed that you stop breathing during your sleep?" and said that this occurs >3e4 times per week were also more likely to have AHI !5 per hour (21% vs 3%; P¼.026). A similar question in the STOP-BANG questionnaire that did not discriminate for frequency of witnessed apneas was endorsed by more subjects, but there were no significant differences between groups. On the ESS, 16% of OSA-positive subjects endorsed a moderate-to-high chance of dozing off while stopped in traffic while driving compared with none in the OSAnegative group (P¼.012). Snoring and fatigue were common among both groups, regardless of OSA status.
We found no evidence of significant differences in maternal or neonatal outcomes between the 2 groups in our exploratory analysis (Table 4 ). There was a trend towards more adverse composite cardiovascular outcomes in the OSApositive group when we combined cases of gestational hypertension, mild and severe preeclampsia, eclampsia, cardiomyopathy, and congestive heart failure (42 % vs 21%; P¼.07). There was also a trend towards more adverse composite peripartum adverse outcomes in the OSA group (postpartum hemorrhage, maternal intensive care unit admission, and postoperative wound infections; 31.6% vs 14.8%; P¼.10).
Comment

Principal findings
We found an OSA prevalence of 24% among pregnant women from 24e35 weeks gestation with extreme obesity, where OSA is defined as AHI !5 events per hour on a type III, unattended home sleep test. Of the patient factors and physical examination findings that were analyzed, age, BMI, neck circumference, frequently witnessed apneas, and likely to fall asleep while driving were associated positively with AHI !5 per hour. However, frequently witnessed apneas and falling asleep while driving were specific, but not sensitive, for OSA status; relatively few women in the OSA group endorsed these signs. We found very poor performance of the previously defined OSA screening tools (BQ, STOP-BANG questionnaire, ASA checklist, and Facco et al 2 score) and sleepiness scale (ESS) to predict OSA status in this cohort of obese pregnant women in mid pregnancy. Although the Facco et al OSA prediction score that was developed in pregnant women was significantly associated with OSA status, it had very low specificity with 100% of the subjects in our cohort who were identified as high risk. 2 There was no significant association between race or ethnicity and OSA status. Although there were trends towards more 
Meaning/clinical implications
Our finding of a 24% prevalence of OSA among pregnant women with extreme obesity was lower than we expected, but it was clinically significant, given the high prevalence of obesity among reproductive age women. Our prevalence may have been underestimated by limitations in the home sleep test device, which cannot detect wakefulness and may underestimate AHI. A recent large, multicenter study suggested a prevalence of OSA among pregnant women of 3e8%, depending on the trimester of pregnancy. 3 In this longitudinal cohort, prepregnancy BMI was an important predictor of OSA both early in pregnancy and in OSA that developed during pregnancy, as we demonstrated here. 16 We found that the BQ, ESS, STOP-BANG questionnaire, and ASA checklist were poor discriminators of OSA status in a cohort of pregnant women with extreme obesity, which is consistent with the findings reported by other groups. 2, 12, 14, 31 Screening tools that previously were validated in nonpregnant populations have not performed well in several studies of pregnant women. However, in our study, the STOP-BANG score approached statistical significance, and a larger study may have detected a significant difference. Facco et al 2 used home sleep testing (Watch-PAT100 device; Itamar Medical Ltd., Israel) to study the reliability of BQ and ESS in a group of pregnant women considered at high risk for OSA (chronic hypertension and/or pregestational diabetes mellitus and/or BMI >30 kg/m 2 and/or a history of preeclampsia in a previous pregnancy) between 6e20 weeks gestation and found poor sensitivity and specificity with both questionnaires for AHI !5 per hour. 2 When they used a multivariable logistic regression analysis on individual components in the questionnaires, they found that prepregnancy BMI, age, chronic hypertension, and frequent snoring were independent risk factors for OSA in a group of pregnant women at high risk for OSA (area under the curve, 0.850; 95% confidence interval, 0.77e0.93; P<.001). However, the mean BMI in that study was 31.9 kg/m 2 , . When we applied the Facco et al tool to this population, 84% of our subjects showed to be at high risk for OSA, whereas only 24% had AHI !5 per hour on home sleep testing. Although screening tools validated in other populations may not be useful in pregnant women, our study confirms that age, prepregnancy BMI, neck circumference, and frequently witnessed apneas are important risk factors for OSA in pregnancy, even in a cohort of women with a high BMI.
Other studies of pregnant women have also found age and BMI to be important risk factors, although our study was the first to examine these risk factors in a cohort of extremely obese women.
1, 14 Louis et al 16 recently proposed a prediction model for OSA risk in pregnancy from the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be cohort. They also found that age and prepregnancy BMI were important risk factors for OSA in both early and mid gestation but included women of all BMIs. In this cohort, frequent snoring (>3 times per week) was also considered predictive of OSA status. Age and BMI are considered important risk factors for OSA in nonpregnant populations, but the age and BMI cut-offs that are used in screening questionnaires are not appropriate to pregnant women. We found a high prevalence of frequent snoring among pregnant women, regardless of OSA status, with no significant differences between the 2 groups (57% vs 74%; P¼.28). However, our ability to explore this variable may have been limited by our study size and the tendency of the home sleep apnea test to underestimate AHI. Therefore, some women who would have been put into the OSA-positive group by more rigorous in-laboratory polysomnography may have been classified as OSA negative by the methods used in this study.
With the exception of neck circumference, we did not find any of the physical examination findings to be associated with OSA status in women with extreme obesity. Physical examination of the upper airway and neck are often used in clinical practice to identify patients at risk for difficult intubation and OSA. The MMS has been studied as an independent predictor of OSA diagnosed by polysomnography. 28 This has not been validated in pregnancy, but it has been shown that MMS changes as pregnancy progresses. 32 The modified MMS (obtained without a protruding tongue) has also been associated with sleep disordered breathing. 29 Neck circumference >41 cm (for women) is included in the STOP-BANG questionnaire. 19 Some studies have also assessed the predictive value of Original Research OBSTETRICS ajog.org other physical examination findings for OSA, such as dental malocclusion or retroplacement of the mandible, thyromental space, tongue scalloping, lateral pharyngeal wall narrowing, and tonsil size in their evaluation of the upper airway. 27, [33] [34] [35] Recent studies have associated OSA in pregnancy with a number of adverse pregnancy outcomes: hypertensive disorders of pregnancy, gestational diabetes mellitus, cardiomyopathy, congestive heart failure, pulmonary edema, and perinatal death. 3, 8, 11 These studies have increased interest in the identification of at-risk women during pregnancy, although future studies are needed to determine whether OSA treatment can mitigate these adverse pregnancy outcomes. In this study, although there were trends towards more composite adverse cardiovascular and peripartum outcomes in the OSA-positive group, the study was underpowered to detect differences in maternal and neonatal outcomes by OSA status.
Strengths and weaknesses
This study was the first study to examine OSA in pregnancy in a high-risk cohort of extremely obese women with the use of objective testing to determine OSA status. The study was also the first to evaluate the OSA in pregnancy risk tool proposed by Facco et al 2 in a novel cohort and to evaluate the value of the physical examination findings (thyromental distance, retrognathia, tongue scalloping, MMS, and modified MMS) to assess OSA risk in obese pregnant women. This study has several limitations. Although we enriched our sample by enrolling only women with BMI !40 kg/ m 2 , the study was small and underpowered to study pregnancy outcomes. Because the observed rate of OSA was lower than expected, only large effect sizes and strong associations were detectable in this cohort. The power of our final analysis was affected negatively by the lower than expected rate of OSA in this patient population, which in and of itself is a novel and reportable result. The poor performance of the risk scores is evidenced not only by the lack of association, which may have been impacted by power, but also by the sensitivity and specificity metrics, which are more robust to sample size. Although our assessment of individual question association may be underpowered to detect effect sizes <2.5, our conclusions about the poor performance of the preexisting risk scores would likely not change given a larger study.
We were able to study women only once during pregnancy at 24e35 weeks gestation and thus cannot determine whether OSA in our cohort was present before pregnancy or whether it developed during pregnancy. Observational studies have shown that the prevalence of OSA increases with gestational age. 1, 3 In addition, we used home sleep apnea testing, not in-laboratory polysomnography, to classify OSA status. Although portable at-home, unattended sleep apnea testing is emerging as a reliable, convenient, and cost-effective method of screening for OSA, inlaboratory overnight polysomnography remains the gold standard for the diagnosis of OSA. Some home sleep test devices have been validated in a pregnant population. 2, 4, 36 The device used in this study, ApneaLink Air, has also been used as a diagnostic tool in other studies of pregnant women 12 and has been validated in other populations, which have included obese, nonpregnant women. 37 One limitation of this home sleep device was its acceptance by pregnant women; 26% of our subjects were excluded from the study because they applied the device incorrectly or for <2 hours. Home sleep apnea testing has limitations in its ability to diagnose OSA. The main limitation of this and other unattended, home sleep apnea assessment devices is that they cannot collect electroencephalography and electromyography results and thus cannot estimate actual sleep time. Therefore, they may overestimate sleep time and underestimate the AHI. Because we used a minimum threshold of AHI !5 per hour to define OSA positive, we believe that we captured most of the women with clinically significant OSA. However, this may have biased our results towards fewer women in the OSA group than would have been found with in-laboratory testing. Another limitation of this study was that we included all sleep studies of at least 2 hours. Longer sleep studies would have captured a more complete picture of the sleep cycle variations.
Conclusion with future research implications
In conclusion, we found that 24% of pregnant women with BMI !40 kg/m 2 between 24e35 weeks gestation have OSA. We did not find the BQ, ESS, STOP-BANG questionnaire, ASA checklist, or Facco et al 2 score to be useful screening tools for OSA in a cohort of obese pregnant women. 
